Legence Corp. plans to list on the Nasdaq under the symbol LGN, offering 26,000,000 shares of class A common stock. It filed a Form S-1 registration statement for an initial public offering on August 15, 2025. As of November 6, 2026, its final prospectus is on file (Form 424B4, April 8, 2026).
Sell to companies like Legence Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · What it is: Final prospectus filed: the offering is priced · 424B4
- · What it is: Registration statement filed · S-1
- · What it is: Final prospectus filed: the offering is priced · 424B4
- · What it is: Registration statement filed · S-1
- · What it is: Final prospectus filed: the offering is priced · 424B4
Legence Corp. filed a Form S-1 registration statement for an initial public offering on 2025-08-15. It has amended it 2 times. It filed its final prospectus on 2026-04-08. Each fact below is quoted from the filing named with it.
Also on the record for Legence Corp.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 18, 2026 | Leadership change: Robert Crisci appointed, Director, and 1 more | — | Leadership changes | Source |
| August 7, 2026 | Stake report, Schedule 13G/A, by BCP 8/BEP 3 Holdings Manager L.L.C. | 46.9% of the class | 5%+ stakes | Source |
| July 29, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.6% of the class | 5%+ stakes | Source |
| June 11, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| May 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 4.4% of the class | 5%+ stakes | Source |
| May 1, 2026 | Stake report, Schedule 13G/A, by BCP 8/BEP 3 Holdings Manager L.L.C. | 61.1% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 2, 2026 | Form D, private offering | $7.25M sold | Form D page | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by BCP 8/BEP 3 Holdings Manager L.L.C. | 67.2% of the class | 5%+ stakes | Source |
| February 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 6.8% of the class | 5%+ stakes | Source |
| January 30, 2026 | Stake report, Schedule 13G, by The Vanguard Group | 5.5% of the class | 5%+ stakes | Source |
| January 2, 2026 | Form D, private offering | $100M sold | Form D page | Source |
Check before you invest in Legence Corp.: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on Legence Corp. and the records around it.
Legence Corp. elsewhere on the record
- Leadership changes Aug 2026
- 5%+ stake filings Aug 2026
- Company profile and every filing Mar 2026
- Form D filing Mar 2026
- Form D filing Jan 2026
- Who owns it
Companies that share a holder
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Also filing to list on the Nasdaq
IPO filings on the Nasdaq in Q2 2026, newest first.
- TEN Holdings, Inc. (Jun 2026)
- One & one Green Technologies. INC (May 2026)
Watch Legence Corp.
Get an email when Legence Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Legence Corp.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Legence Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Legence Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
20 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 14 records.
What the filings say
Listing
Our Class A Common Stock is listed on The Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “LGN.” On April 7, 2026, the last reported sale price of our Class A Common Stock on the Nasdaq was $54.98 per share.From the 424B4 filed 2026-04-08
Shares offered
We are offering 26,000,000 shares of our Class A common stock.From the 424B4 filed 2025-09-15
Revenue
For the year ended September 30, 2025 and three months ended December 31, 2025, respectively, Bowers generated total revenue of approximately $767 million and $262 million, net income of approximately $69 million and $22 million and EBITDA of approximately $72 million and $23 million.From the S-1 filed 2026-04-06
Net loss or income
For the year ended December 31, 2025, we generated $2,550.5 million in revenue, $77.3 million in net loss and $298.8 million in Adjusted EBITDA representing a Net Loss Margin of (3.0)% and Adjusted EBITDA Margin of 11.7%.From the S-1 filed 2026-04-06
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-08-15 | Registration statement filed | S-1 |
| 2025-08-25 | Registration statement amended | S-1/A |
| 2025-09-02 | Registration statement amended | S-1/A |
| 2025-09-15 | Final prospectus filed: the offering is priced | 424B4 |
| 2025-12-09 | Registration statement filed | S-1 |
| 2025-12-15 | Final prospectus filed: the offering is priced | 424B4 |
| 2026-04-06 | Registration statement filed | S-1 |
| 2026-04-08 | Final prospectus filed: the offering is priced | 424B4 |
Legence Corp.'s full funding historyFounders and team
Tools for this story
Each opens in a new tab, filled in for Legence Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.